Stockreport

Northwest Biotherapeutics Reports Positive Top-Line Results From Phase 3 Trial of DCVax®-L for Glioblastoma

NORTHWEST BIOTHRPUTCS INC  (NWBO) 
US:NASDAQ Investor Relations: nwbio.com/investors-media
PDF Both Median Survival and "Long Tail" of Extended Survival Were Increased In Both Newly Diagnosed and Recurrent GlioblastomaResults Featured In JAMA Oncology Peer Reviewe [Read more]